Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells

Nature Reviews Immunology

Volumn 8, Issue 12, 2008, Pages 935-947

  Merad, Miriam ^a   Ginhoux, Florent ^a   Collin, Matthew ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LANGERIN;

CELL FUNCTION; CELL MATURATION; CELL SUBPOPULATION; CYTOLOGY; DENDRITIC CELL; EPIDERMIS; HISTIOCYTOSIS; HISTOCOMPATIBILITY; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGICAL TOLERANCE; IN VIVO CULTURE; IN VIVO STUDY; LANGERHANS CELL; LYMPH NODE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; SKIN ALLERGY; STEADY STATE;

ANIMALS; ANTIGENS, CD; ANTIGENS, SURFACE; EPIDERMIS; HOMEOSTASIS; HUMANS; LANGERHANS CELLS; LECTINS, C-TYPE; LYMPH NODES; MANNOSE-BINDING LECTINS; MICE;

EID: 56749152272     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2455     Document Type: Review

References (149)

1. Banchereau, J. & Steinman, R. M. Dendritic cells and the control of immunity. Nature 392, 245-252 (1998).
2. Valladeau, J. et al. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12, 71-81 (2000). This paper was the first to identify langerin on the surface of human LCs and to show that langerin induces the formation of Birbeck granules.
3. Turville, S. G. et al. Diversity of receptors binding HIV on dendritic cell subsets. Nature Immunol. 3, 975-983 (2002).
4. de Witte, L. et al. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nature Med. 13, 367-371 (2007). This study reveals that langerin leads to HIV-1 degradation.
5. + DCs in the skin that develop and function independently of LCs.
6. + dendritic cells that develop and function independently of epidermal Langerhans cells. J. Exp. Med. 204, 3119-3131 (2007).
7. + dendritic cells. J. Exp. Med. 204, 3147-3156 (2007).
8. Wang, L. et al. Langerin expressing cells promote skin immune responses under defined conditions. J. Immunol. 180, 4722-4727 (2008).
9. -/- mice and that monocytes repopulate LCs in inflamed skin in vivo in mice.
10. Langerhans, P. Uber die Nerven der menschlichen Haut. Virchows. Arch. Pathol. 44, 325-337 (1868). In this paper, entitled "On the nerves of the human skin", Paul Langerhans reported for the first time the presence of large cells with long dendrites in the epidermis of human skin.
11. Stingl, G., Tamaki, K. & Katz, S. I. Origin and function of epidermal Langerhans cells. Immunol. Rev. 53, 149-174 (1980).
12. Schuler, G. et al. Murine epidermal Langerhans cells as a model to study tissue dendritic cells. Adv. Exp. Med. Biol. 329, 243-249 (1993).
13. Valladeau, J. & Saeland, S. Cutaneous dendritic cells. Semin. Immunol. 17, 273-283 (2005).
14. + dendritic epidermal T cells as constituents of skin-associated lymphoid tissue. J. Invest. Dermatol. 94, 58S-63S (1990).
15. Birbeck, M. D., Breathnach, A. S. & Everall, J. D. An electron microscope study of basal melanocytes and high-level clear cells (langerhans cells) in vitiligo. J. Invest. Dermatol. 37, 51 (1961). This is the first description of the presence of the conspiscuous Birbeck granules in Langerhans cells.
16. Wolff, K. The fine structure of the Langerhans cell granule. J. Cell Biol. 35, 468-473 (1967).
17. Tang, A., Amagai, M., Granger, L. G., Stanley, J. R. & Udey, M. C. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature 361, 82-85 (1993).
18. 7-integrin heterodimer) expressed on the cell surface of T cells can bind the adhesion molecule E-cadherin on epithelial cells.
19. Borkowski, T. A., Letterio, J. J., Farr, A. G. & Udey, M. C. A role for endogenous transforming growth factor β1 in Langerhans cell biology: the skin of transforming growth factor β1 null mice is devoid of epidermal Langerhans cells. J. Exp. Med. 184, 2417-2422 (1996). This study is the first demonstration that TGFβ1 is crucial for LC development in vivo.
20. Inaba, K. et al. Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. I. Expression on dendritic cells and other subsets of mouse leukocytes. Cell. Immunol. 163, 148-156 (1995).
21. Jiang, W. et al. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 375, 151-155 (1995).
22. Fithian, E. et al. Reactivity of Langerhans cells with hybridoma antibody. Proc. Natl Acad. Sci. USA 78, 2541-2544 (1981).
23. Hunger, R. E. et al. Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells. J. Clin. Invest. 113, 701-708 (2004).
24. Ronger-Savle, S. et al. TGFβ inhibits CD1d expression on dendritic cells. J. Invest. Dermatol. 124, 116-118 (2005).
25. Mc Dermott, R. et al. Birbeck granules are subdomains of endosomal recycling compartment in human epidermal Langerhans cells, which form where langerin accumulates. Mol. Biol. Cell 13, 317-335 (2002).
26. Valladeau, J. et al. Identification of mouse langerin/CD207 in Langerhans cells and some dendritic cells of lymphoid tissues. J. Immunol. 168, 782-792 (2002).
27. Takahara, K. et al. Identification and expression of mouse Langerin (CD207) in dendritic cells. Int. Immunol. 14, 433-444 (2002).
28. Kissenpfennig, A. et al. Disruption of the langerin/CD207 gene abolishes Birbeck granules without a marked loss of Langerhans cell function. Mol. Cell Biol. 25, 88-99 (2005).
29. Verdijk, P. et al. A lack of Birbeck granules in Langerhans cells is associated with a naturally occurring point mutation in the human Langerin gene. J. Invest. Dermatol. 124, 714-717 (2005).
30. Kelly, R. H., Balfour, B. M., Armstrong, J. A. & Griffiths, S. Functional anatomy of lymph nodes. II. Peripheral lymph-borne mononuclear cells. Anat. Rec. 190, 5-21 (1978). This is one of the first studies to show the presence of veiled (dendritic) cells in lymphatic vessels.
31. Drexhage, H. A., Mullink, H., de Groot, J., Clarke, J. & Balfour, B. M. A study of cells present in peripheral lymph of pigs with special reference to a type of cell resembling the Langerhans cell. Cell Tissue Res. 202, 407-430 (1979).
32. Hemmi, H. et al. Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factor-β-dependent cells. Int. Immunol. 13, 695-704 (2001).
33. Stoitzner, P., Tripp, C. H., Douillard, P., Saeland, S. & Romani, N. Migratory Langerhans cells in mouse lymph nodes in steady state and inflammation. J. Invest. Dermatol. 125, 116-125 (2005).
34. Macatonia, S. E., Knight, S. C., Edwards, A. J., Griffiths, S. & Fryer, P. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies. J. Exp. Med. 166, 1654-1667 (1987).
35. Randolph, G. J., Ochando, J. & Partida-Sanchez, S. Migration of dendritic cell subsets and their precursors. Annu. Rev. Immunol. 26, 293-316 (2008).
36. Larsen, C. P. et al. Migration and maturation of Langerhans cells in skin transplants and explants. J. Exp. Med. 172, 1483-1493 (1990).
37. Pierre, P. et al. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388, 787-792 (1997).
38. Ruedl, C., Koebel, P., Bachmann, M., Hess, M. & Karjalainen, K. Anatomical origin of dendritic cells determines their life span in peripheral lymph nodes. J. Immunol. 165, 4910-4916 (2000).
39. Ohl, L. et al. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21, 279-288 (2004). This is the first paper to identify the crucial role of CCR7 in skin-DC migration to the draining lymph nodes.
40. Jakob, T., Ring, J. & Udey, M. C. Multistep navigation of Langerhans/dendritic cells in and out of the skin. J. Allergy Clin. Immunol. 108, 688-696 (2001).
41. Inaba, K. et al. High levels of a major histocompatibility complex II-self peptide complex on dendritic cells from the T cell areas of lymph nodes. J. Exp. Med. 186, 665-672 (1997).
42. Katz, S. I., Tamaki, K. & Sachs, D. H. Epidermal Langerhans cells are derived from cells originating in bone marrow. Nature 282, 324-326 (1979).
43. Frelinger, J. G., Hood, L., Hill, S. & Frelinger, J. A. Mouse epidermal Ia molecules have a bone marrow origin. Nature 282, 321-323 (1979). References 42 and 43 were the two first studies to show the haematopoietic origin of LCs.
44. Merad, M. et al. Langerhans cells renew in the skin throughout life under steady-state conditions. Nature Immunol. 3, 1135-1141 (2002). This is the first paper to describe how LCs replenish in situ in the steady state but are repopulated by blood precursor cells during skin injury. This paper also describes for the first time that LC repopulation in inflamed skin depends on CCR2.
45. Iijima, N., Linehan, M. M., Saeland, S. & Iwasaki, A. Vaginal epithelial dendritic cells renew from bone marrow precursors. Proc. Natl Acad. Sci. USA 104, 19061-19066 (2007).
46. Holt, P. G., Haining, S., Nelson, D. J. & Sedgwick, J. D. Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways. J. Immunol. 153, 256-261 (1994).
47. Liu, K. et al. Origin of dendritic cells in peripheral lymphoid organs of mice. Nature Immunol. 8, 578-583 (2007). This study shows that DCs cycle in situ in lymphoid organs but are maintained by circulating precursor cells.
48. Merad, M. et al. Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nature Med. 10, 510-517 (2004).
49. Vishwanath, M. et al. Development of intravital intermittent confocal imaging system for studying Langerhans cell turnover. J. Invest. Dermatol. 126, 2452-2457 (2006).
50. Kamath, A. T., Henri, S., Battye, F., Tough, D. F. & Shortman, K. Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 100, 1734-1741 (2002).
51. Kissenpfennig, A. et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22, 643-654 (2005).
52. Bennett, C. L. et al. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J. Cell Biol. 169, 569-576 (2005). References 51 and 52 were the first two papers to describe the langerin-DTR mice.
53. + T cells against systemic pathogen infection.
54. Czernielewski, J., Vaigot, P. & Prunieras, M. Epidermal Langerhans cells - a cycling cell population. J. Invest. Dermatol. 84, 424-426 (1985). The first study to report that LCs cycle in situ.
55. Czernielewski, J. M. & Demarchez, M. Further evidence for the self-reproducing capacity of Langerhans cells in human skin. J. Invest. Dermatol. 88, 17-20 (1987).
56. Giacometti, L. & Montagna, W. Langerhans cells: uptake of tritiated thymidine. Science 157, 439-440 (1967).
57. Krueger, G. G., Daynes, R. A. & Emam, M. Biology of Langerhans cells: selective migration of Langerhans cells into allogeneic and xenogeneic grafts on nude mice. Proc. Natl Acad. Sci. USA 80, 1650-1654 (1983).
58. Kanitakis, J., Petruzzo, P. & Dubernard, J. M. Turnover of epidermal Langerhans' cells. N. Engl. J. Med. 351, 2661-2662 (2004). A study showing that in one patient that received a limb graft, LCs remained of host origin and were not replaced by blood-derived precursor cells for over 1 year after transplant.
59. Collin, M. P. et al. The fate of human Langerhans cells in hematopoietic stem cell transplantation. J. Exp. Med. 203, 27-33 (2006). This study shows that, in the absence of graft-versus-host disease, host LCs can remain in the skin despite complete donor-derived chimerism in the blood.
60. Collin, M. P., Bogunovic, M. & Merad, M. DC homeostasis in hematopoietic stem cell transplantation. Cytotherapy 9, 521-531 (2007).
61. Miyauchi, S. & Hashimoto, K. Epidermal Langerhans cells undergo mitosis during the early recovery phase after ultraviolet-B irradiation. J. Invest. Dermatol. 88, 703-708 (1987).
62. Kumamoto, T. et al. Hair follicles serve as local reservoirs of skin mast cell precursors. Blood 102, 1654-1660 (2003). This is the first demonstration that the hair follicle is also a reservoir for the mast-cell precursor.
63. Blanpain, C. & Fuchs, E. Epidermal stem cells of the skin. Annu. Rev. Cell Dev. Biol. 22, 339-373 (2006).
64. + B7-deficient Langerhans cells that repopulate epidermis after UVB exposure. J. Invest. Dermatol. 110, 422-427 (1998). This study shows that after exposure to ultraviolet B radiation that depletes epidermal LCs but does not affect the hair follicle, LCs are repopulated from the hair follicle.
65. Bennett, C. L., Noordegraaf, M., Martina, C. A. & Clausen, B. E. Langerhans cells are required for efficient presentation of topically applied hapten to T cells. J. Immunol. 179, 6830-6835 (2007). This is one of the first demonstrations that LCs are required to initiate T-cell priming against topical antigens.
66. Kaplan, D. H. et al. Autocrine/paracrine TGF?1 is required for the development of epidermal Langerhans cells. J. Exp. Med. 204, 2545-2552 (2007). This study shows that autocrine TGFβ1 is required for LC development.
67. + hemopoietic progenitors. J. Immunol. 157, 1499-1507 (1996).
68. Geissmann, F. et al. Transforming growth factor β1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J. Exp. Med. 187, 961-966 (1998). This is the first demonstration that human monocytes can differentiate into LCs in vitro.
69. Hacker, C. et al. Transcriptional profiling identifies Id2 function in dendritic cell development. Nature Immunol. 4, 380-386 (2003). This is the first demonstration that ID2 is required for LC development.
70. Fainaru, O. et al. Runx3 regulates mouse TGF-β-mediated dendritic cell function and its absence results in airway inflammation. EMBO J. 23, 969-979 (2004).
71. Witmer-Pack, M. D. et al. Identification of macrophages and dendritic cells in the osteopetrotic (op/op) mouse. J. Cell Sci. 104, 1021-1029 (1993).
72. Lin, H. et al. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 320, 807-811 (2008).
73. Stanley, E. R. et al. Biology and action of colony-stimulating factor-1. Mol. Reprod. Dev. 46, 4-10 (1997).
74. Onai, N., Obata-Onai, A., Schmid, M. A. & Manz, M. G. Flt3 in regulation of type-I interferon producing and dendritic cell development. Ann. NY Acad. Sci. 1106, 253-261 (2007).
75. Bogunovic, M. et al. Identification of a radio-resistant and cycling dermal dendritic cell population in mice and men. J. Exp. Med. 203, 2627-2638 (2006).
76. Sato, N. et al. CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, B cell outgrowth, and sustained neutrophilic inflammation. J. Exp. Med. 192, 205-218 (2000).
77. Cook, D. N. et al. CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 12, 495-503 (2000).
78. Vanbervliet, B. et al. Sequential involvement of CCR2 and CCR6 ligands for immature dendritic cell recruitment: possible role at inflamed epithelial surfaces. Eur. J. Immunol. 32, 231-242 (2002).
79. + cells differentiate into Langerhans cells. Nature Immunol. 2, 1151-1158 (2001).
80. Schaerli, P., Willimann, K., Ebert, L. M., Walz, A. & Moser, B. Cutaneous CXCL14 targets. Blood precursors to epidermal niches for Langerhans cell differentiation. Immunity 23, 331-342 (2005).
81. Reis e Sousa, C. Dendritic cells in a mature stage. Nature Rev. Immunol. 6, 476-483 (2006).
82. Jiang, A. et al. Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation. Immunity 27, 610-624 (2007). This is the first paper to describe an alternative DC-maturation pathway that leads to the upregulation of CCR7 without inducing cytokine release and is thought to have a key role in the induction of tolerance.
83. Banchereau, J. et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811 (2000).
84. Stoitzner, P. et al. Visualization and characterization of migratory Langerhans cells in murine skin and lymph nodes by antibodies against Langerin/CD207. J. Invest. Dermatol. 120, 266-274 (2003).
85. Geissmann, F. et al. Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J. Exp. Med. 196, 417-430 (2002).
86. Douillard, P. et al. Mouse lymphoid tissue contains distinct subsets of langerin/CD207 dendritic cells, only one of which represents epidermal-derived Langerhans cells. J. Invest. Dermatol. 125, 983-994 (2005).
87. Cheong, C. et al. Production of monoclonal antibodies that recognize the extracellular domain of mouse langerin/CD207. J. Immunol. Methods 324, 48-62 (2007).
88. Flacher, V. et al. Expression of langerin/CD207 reveals dendritic cell heterogeneity between inbred mouse strains. Immunology 123, 339-347 (2008).
89. Mayer, W. J. et al. Characterization of antigen-presenting cells in fresh and cultured human corneas using novel dendritic cell markers. Invest. Ophthalmol. Vis. Sci. 48, 4459-4467 (2007).
90. Santoro, A. et al. Recruitment of dendritic cells in oral lichen planus. J. Pathol. 205, 426-434 (2005).
91. 7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J. Immunol. 176, 2161-2172 (2006).
92. + dendritic cells in the regulation of tissue-selective T cell homing. J. Exp. Med. 202, 1063-1073 (2005).
93. + cells in human tissue other than the skin.
94. + cells in human kidneys.
95. + dendritic cells display unique functional properties that are conserved between mice and humans. J. Exp. Med. 205, 2139-2149 (2008).
96. Kamath, A. T. et al. The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J. Immunol. 165, 6762-6770 (2000).
97. Fogg, D. K. et al. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 311, 83-87 (2006).
98. Massberg, S. et al. Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues. Cell 131, 994-1008 (2007).
99. + T cell tolerance. J. Exp. Med. 196, 1627-1638 (2002). This is the first demonstration that targeting antigens to DCs in the steady state leads to tolerance.
100. Dudziak, D. et al. Differential antigen processing by dendritic cell subsets in vivo. Science 315, 107-111 (2007).
101. Schuler, G. & Steinman, R. M. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 161, 526-546 (1985). This study was the first to show that Langerhans cells can differentiate in vitro into DCs that can prime naive T cells.
102. + T cells following epidermal HSV infection.
103. + T cell immunity in recombinant lentivector-mediated genetic immunization. Immunity 24, 643-656 (2006). This study shows that migratory skin DCs prime antigen-specific T cells after lentivirus-vector infection of the skin.
104. Jones, C. A. et al. Herpes simplex virus type 2 induces rapid cell death and functional impairment of murine dendritic cells in vitro. J. Virol. 77, 11139-11149 (2003).
105. Bosnjak, L. et al. Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells. J. Immunol. 174, 2220-2227 (2005).
106. Leon, B., Lopez-Bravo, M. & Ardavin, C. Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 26, 519-531 (2007).
107. Sacks, D. L. Metacyclogenesis in Leishmania promastigotes. Exp. Parasitol. 69, 100-103 (1989).
108. + T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major. J. Immunol. 168, 3992-4000 (2002).
109. H1-cell responses, whereas dermal DCs are better at priming follicular T-helper cells and inducing B-cell antibody switching.
110. Ueno, H. et al. Dendritic cell subsets in health and disease. Immunol. Rev. 219, 118-142 (2007).
111. Stoecklinger, A. et al. Epidermal langerhans cells are dispensable for humoral and cell-mediated immunity elicited by gene gun immunization. J. Immunol. 179, 886-893 (2007).
112. Stoitzner, P. et al. Tumor immunotherapy by epicutaneous immunization requires langerhans cells. J. Immunol. 180, 1991-1998 (2008). This is the first demonstration that LCs are required for the induction of the antitumour immune response following epidermal vaccination with tumour antigens.
113. Kaplan, D. H., Jenison, M. C., Saeland, S., Shlomchik, W. D. & Shlomchik, M. J. Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 23, 611-620 (2005).
114. Steinman, R. M., Hawiger, D. & Nussenzweig, M. C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685-711 (2003).
115. Waithman, J. et al. Skin-derived dendritic cells can mediate deletional tolerance of class I-restricted self-reactive T cells. J. Immunol. 179, 4535-4541 (2007).
116. Loser, K. et al. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nature Med. 12, 1372-1379 (2006).
117. Mehling, A. et al. Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity. J. Exp. Med. 194, 615-628 (2001).
118. - but not plasmacytoid dendritic cells. J. Exp. Med. 205, 1621-1634 (2008).
119. Belz, G. T. et al. Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. Proc. Natl Acad. Sci. USA 101, 8670-8675 (2004).
120. + T cells. J. Immunol. 178, 6861-6866 (2007).
121. Coppes-Zantinga, A. & Egeler, R. M. The Langerhans cell histiocytosis X files revealed. Br. J. Haematol. 116, 3-9 (2002).
122. Nezelof, C., Basset, F. & Rousseau, M. F. Histiocytosis X histogenetic arguments for a Langerhans cell origin. Biomedicine 18, 365-371 (1973).
123. Geissmann, F. et al. Differentiation of Langerhans cells in Langerhans cell histiocytosis. Blood 97, 1241-1248 (2001).
124. Emile, J. F., Fraitag, S., Leborgne, M., de Prost, Y. & Brousse, N. In situ expression of activation markers by Langerhans' cells containing GM-CSF. Adv. Exp. Med. Biol. 378, 101-103 (1995).
125. Nezelof, C. & Basset, F. An hypothesis Langerhans cell histiocytosis: the failure of the immune system to switch from an innate to an adaptive mode. Pediatr. Blood Cancer 42, 398-400 (2004). This is the first study showing that cells in histiocytosis X lesions contain Birbeck granules, which suggests their potential LC origin, and proposed that the term histiocytosis X should be replaced with the term Langerhans-cell histiocytosis.
126. Yu, R. C., Chu, C., Buluwela, L. & Chu, A. C. Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis. Lancet 343, 767-768 (1994).
127. Willman, C. L. et al. Langerhans'-cell histiocytosis (histiocytosis X) - a clonal proliferative disease. N. Engl. J. Med. 331, 154-160 (1994).
128. Senechal, B. et al. Expansion of regulatory T cells in patients with Langerhans cell histiocytosis. PLoS Med. 4, e253 (2007).
129. Schouten, B. et al. Expression of cell cycle-related gene products in Langerhans cell histiocytosis. J. Pediatr. Hematol. Oncol. 24, 727-732 (2002).
130. Savell, V. H. Jr, Sherman, T., Scheuermann, R. H., Siddiqui, A. M. & Margraf, L. R. Bcl-2 expression in Langerhans' cell histiocytosis. Pediatr. Dev. Pathol. 1, 210-215 (1998).
131. Bjorck, P., Banchereau, J. & Flores-Romo, L. CD40 ligation counteracts Fas-induced apoptosis of human dendritic cells. Int. Immunol. 9, 365-372 (1997).
132. Wong, B. R. et al. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med. 186, 2075-2080 (1997).
133. Bechan, G. I., Egeler, R. M. & Arceci, R. J. Biology of Langerhans cells and Langerhans cell histiocytosis. Int. Rev. Cytol. 254, 1-43 (2006).
134. + dendritic cells leads to progressive multisystem histiocytosis. Blood 111, 2073-2082 (2008).
135. Pileri, S. A. et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 41, 1-29 (2002).
136. Figdor, C. G., van Kooyk, Y. & Adema, G. J. C-type lectin receptors on dendritic cells and Langerhans cells. Nature Rev. Immunol. 2, 77-84 (2002).
137. Idoyaga, J. et al. Cutting Edge: Langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo. J. Immunol. 180, 3647-3650 (2008).
138. Piguet, V. & Steinman, R. M. The interaction of HIV with dendritic cells: outcomes and pathways. Trends Immunol. 28, 503-510 (2007).
139. Hladik, F. & McElrath, M. J. Setting the stage: host invasion by HIV. Nature Rev. Immunol. 8, 447-457 (2008).
140. Fahrbach, K. M. et al. Activated CD34-derived Langerhans cells mediate transinfection with human immunodeficiency virus. J. Virol. 81, 6858-6868 (2007).
141. Riedl, E., Tada, Y. & Udey, M. C. Identification and characterization of an alternatively spliced isoform of mouse Langerin/CD207. J. Invest. Dermatol. 123, 78-86 (2004).
142. Ward, E. M., Stambach, N. S., Drickamer, K. & Taylor, M. E. Polymorphisms in human langerin affect stability and sugar binding activity. J. Biol. Chem. 281, 15450-15456 (2006).
143. Boes, M. et al. T-cell engagement of dendritic cells rapidly rearranges MHC class II transport. Nature 418, 983-988 (2002).
144. Fukuzumi, T. et al. Differences in irradiation susceptibility and turnover between mucosal and connective tissue-type mast cells of mice. Exp. Hematol. 18, 843-847 (1990).
145. Matsumoto, Y. & Fujiwara, M. Absence of donor-type major histocompatibility complex class I antigen-bearing microglia in the rat central nervous system of radiation bone marrow chimeras. J. Neuroimmunol. 17, 71-82 (1987).
146. Berland, R. & Wortis, H. H. Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 20, 253-300 (2002).
147. Merad, M. & Ginhoux, F. Dendritic cell genealogy: a new stem or just another branch? Nature Immunol. 8, 1199-1201 (2007).
148. Takahashi, K. et al. Heterogeneity of dendritic cells in human superficial lymph node: in vitro maturation of immature dendritic cells into mature or activated interdigitating reticulum cells. Am. J. Pathol. 153, 745-755 (1998).
149. Schiavoni, G. et al. ICSBP is critically involved in the normal development and trafficking of Langerhans cells and dermal dendritic cells. Blood 103, 2221-2228 (2004).